BioRestorative Therapies Presents Preliminary Clinical Data from Phase 2 Study of BRTX-100 in Chronic Lumbar Disc Disease

February 5, 2024

https://www.globenewswire.com/news-release/2024/02/05/2823422/0/en/BioRestorative-Therapies-Presents-Preliminary-Clinical-Data-from-Phase-2-Study-of-BRTX-100-in-Chronic-Lumbar-Disc-Disease.html

— Preliminary data includes 26 and 52-week follow-up end points as part of ongoing Phase 2 trial —

— Company to host webcasted conference call today at 8:30am EST —

Read more at globenewswire.com

Related news for (BRTX)

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.